The company describes EndoArt as the world’s first synthetic endothelial layer for the treatment of chronic corneal edema.

The US Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval to EyeYon Medical for ...

Dublin, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The "Corneal Edema Market - A Global and Regional Analysis: Focus on Country and Regional Analysis - Analysis and Forecast, 2025-2035" report has been added ...

Precise Bio Inc., a Greensboro-based clinical-stage regenerative medicine company, has announced the world’s first transplant ...

An analysis of global pharmacovigilance data links higher-dose aflibercept to increased ocular adverse events vs aflibercept 2 mg and faricimab.

With 15 new measles cases, South Carolina now has the second-largest current outbreak in the country, with more than 300 ...

The campaign to prevent and treat these diseases has seen great success thanks to a USAID program. Now that program is gone.

“Transient vision loss is never something to brush aside,” Deobhakta emphasized. “Even if vision returns after a minute or ...

The Center for Biosimilars connects professionals with insights on biosimilars, health economics, regulatory outcomes, and ...

Allergic conjunctivitis may be related to sleep disturbances in what may be a “self-perpetuating loop,” according to a poster ...

Precise Bio has reported the first successful human implantation of its 3D-printed cornea implant, constructed of functional human eye cells cultured in a laboratory. The company described the ...